Cancer

The interplay between cancer and antimicrobial resistance

Infections are the second leading cause of death in cancer patients, after the cancer itself; Zisis Kozlakidis and Shalini Jayasekar Zurn discuss the challenges surrounding the interplay between cancer and antimicrobial resistance (AMR).

The challenge of sustainability in cancer care

All.Can shares their profound insights into the challenges concerning the need to improve the efficiency of cancer care, focusing on better outcomes for patients Healthcare...

Lymphoma – what’s that?

Experts from the Lymphoma Association offer their thoughts on the extent of lymphoma in the UK today and how treatment and diagnosis can improve Every...

The provision of effective cross-border healthcare

Professor Ruth Ladenstein from SIOPE (the European Society for Paediatric Oncology) discusses how ERN PaedCan facilitates effective cross-border healthcare The European Commission launched 24 different...

The future of the Danish Ministry of Health

Jonathan Miles from Open Access Government explored the work the Danish Ministry of Health does to improve health policy across the country The Danish Ministry...

Living with Leukaemia

Bethany Torr, campaigns and advocacy officer at Leukaemia Care introduces ‘Leukaemia’ and its different forms and explains how people live with the disease Leukaemia’ is...

Fostering and supporting excellence in clinical pharmacy practice

Islam Elkonaissi and Zahra Laftah from the UKCPA explore the British model of supporting excellence in clinical pharmacy practice In the UK, evidence that pharmacists...

Early stage diagnosis – spotting early stage cancer events

Cecilia Van Cauwenberghe, Vandana Iyer and Bhargav Rajan from Frost & Sullivan examine of how nanotechnology helps spot early stage cancer

Dose-finding trials: why not to use algorithmic designs

Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University sheds light on dose-finding trials

Publishing national chemotherapy data

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article

Tumour-host interactions, paediatric sarcomas, and cancer progression

Ivan Stamenkovic, professor of experimental pathology at the University of Lausanne underlines research taking place around cancer progression Cancer progression, meaning the evolution of localised...

Developing IOT in healthcare

Jon Lee-Davey, IoT Health Lead at Vodafone, and Bernard Vrijens, from the University of Liege explain how IoT in healthcare can revolutionise hospitals

Personalising antibody directed therapy in Acute Myeloid Leukaemia (AML)

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research explores the current progress in Acute Myeloid Leukaemia (AML)

NHS approves new ‘life extending’ lung cancer drug

After extended campaigns from charities and prominent figures, a lung cancer drug said to extend the life of sufferers has been made available on...

Understanding cancer through molecular cell biology

Progress in Targeted Therapy and Immunotherapy of Cancer Requires Rethinking of European Reimbursement Practices for Mutation Testing

Focusing on paediatric cancers

Epigenetic changes play a critical role in the development of paediatric cancers. Ivan Stamenkovic, Professor of Pathology, explains

Photodynamic Therapy – radiotherapy for the 21st Century

Photodynamic Therapy is a treatment that combines a photosensitizing drug, visible light and oxygen to kill cancer cells. Professor Eli Glatstein explains

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders